Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells

Kidney International

Volumn 57, Issue 4, 2000, Pages 1472-1483

  Lynn, Edward G ^a   Siow, Yaw L ^a   Karmin, O ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cytokines; Foam cells; Focal glomerulosclerosis; Lipoproteins; Monocyte chemoattractant protein 1

Indexed keywords

DILTIAZEM; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE C; STAUROSPORINE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; FOAM CELL; FOCAL GLOMERULONEPHRITIS; IMMUNOASSAY; LEUKOCYTE ADHERENCE; MESANGIUM CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034033240     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00992.x     Document Type: Conference Paper

References (74)

1. 1. EDDY AA, SCHNAPER HW: The nephrotic syndrome: From the simple to the complex. Semin Nephrol 18:304-316, 1998
2. 2. WEENING JJ, BEUKERS JJ, GROND J, ELEMA JD: Genetic factors in focal segmental glomerulosclerosis. Kidney Int 29:789-798, 1986
3. 3. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
4. 4. GRONE H-J, WALLI AK, GRONE EF: Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis. Clin Invest 71:834-839, 1993
5. 5. JACOBSEN HR: Chronic renal insufficiency: Pathophysiology. Lancet 338:419-423, 1991
6. 6. GUIJARRO C, KEANE WF: Lipid abnormalities and changes in plasma proteins in glomerular diseases and chronic renal failure. Curr Opin Nephrol Hypertens 2:372-379, 1993
7. 7. GUIJARRO C, KEANE WF: Lipid-induced glomerular injury. Nephron 67:1-6, 1994
8. 8. DIAMOND JR, KARNOVSKY MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917-924, 1988
9. 9. DIAMOND JR: Effect of lipid abnormalities on the progression of renal damage: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39(Suppl 31):S29-S34, 1991
10. 10. APPEL G: Lipid abnormalities in renal disease. Kidney Int 39:169-183, 1991
11. 11. CRIQUI MH, HEISS G, COHN R, COWAN LD, SUCHINDRAN CM, BANGDIWALA S, KRITCHEVSKY S, JACOBS DR JR, O'GRADY HK, DAVIS CE: Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328:1220-1225, 1993
12. 12. BLANKENHORN DH, NESSIM SA, JOHNSON RL, SANMARCO ME, AZEN SO, CASHIN-HEMPHILL L: Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257:3233-3240, 1987
13. 13. BLANKENHORN DH, SELZER RH, CRAWFORD DW, BARTH JD, LIU CR, MACK WJ, ALAUPOVIC P: Beneficial effects of colestipol-niacin therapy on the common carotid artery: Two-and four-year reduction of intima-media thickness measured by ultrasound. Circulation 88:20-28, 1993
14. 14. HODIS HN, MACK WJ, AZEN SO, ALAUPOVIC P, POGODA JM, LABREE L, HEMPHILL LC, KRAMSCH DM, BLANKENHORN DH: Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/ moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 90:42-49, 1994
15. 15. HODIS HN, MACK WJ, LABREE L, SELZER RH, LIU C, LIU C, ALAUPOVIC P, KWONG FH, AZEN SP: Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized, controlled clinical trial. Ann Intern Med 124:548-556, 1996
16. 16. MACK WJ, KRAUSS R, HODIS HN: Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS): Treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vasc Biol 16:697-704, 1996
17. 17. WHEELER DC, BERNARD DB: Lipid abnormalities in the nephrotic syndrome: Causes, consequences and treatment. Am J Kidney Dis 23:331-346, 1994
18. 18. AVRAM MM: Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: A role for lipoprotein glomerulopathy. Am J Med 87:39N-41N, 1987
19. 19. SUZAKI K, KOBORI S, UENO S, UEHARA M, KAYASHIMA T, TAKEDA H, FUKAUDA S, TAKAHASHI K, NAKAMURA N, UZAWA H, SHICHIRI M: Effect of plasmapheresis on familial type III hypolipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus. Atherosclerosis 80:181-189, 1990
20. 20. LEE HS, LEE JS, HOH HI, KO KW: Intraglomerular lipid deposition in routine biopsies. Clin Nephrol 36:67-75, 1991
21. 21. HORITA K, ETO M, MAKINO I: Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis 107:203-211, 1994
22. 22. SEO T, ST. CLAIR RW: Heparan sulfate proteoglycans mediate internalization and degradation of β-VLDL and promote cholesterol accumulation by pigeon macrophages. J Lipid Res 38:765-779, 1997
23. 23. NISHIKAWA T, KOBORI S, TAKEDA H, HIGASHI T, SATO Y, SASAHARA T, YANO T, KASHO M, ANAMI Y, SHICHIRI M: β-Migrating very low density lipoproteins induced foam cell formation in mouse mesangial cells. Atherosclerosis 114:123-132, 1995
24. 24. ANAMI Y, KOBORI S, SAKAI M, KASHO M, NISHIKAWA T, YANO T, MATSUDA H, MATSUMURA T, TAKEMURA T, SHICHIRI M: Human β-migrating very low density lipoprotein induces foam cell formation in human mesangial cells. Atherosclerosis 135:225-234, 1997
25. 25. HURT-CAMEJO E, CAMEJO G, ROSENGREN B, LOPEZ F, WIKLUND O, BONDJERS G: Differential uptake of proteoglycan-selected subfractions of LDL by human macrophages. J Lipid Res 31:1387-1398, 1990
26. 26. BRADY HR, DENTON MD, JIMINEZ W, TAKATA S, PALLISER D, BRENNER BM: Chemoattractants provoke monocyte adhesion to human mesangial cells and mesangial cell injury. Kidney Int 42:1169-1177, 1992
27. 27. ROVIN BH, YOSHIUMURA T, TAN L: Cytokine-induced production of monocyte chemoattractant protein-1 by human mesangial cells. J Immunol 148:2148-2153, 1992
28. 28. GRANDE JP, JONES ML, SWENSON CL, KILLEN PD, WARREN JS: Lipopolysaccharide induces monocyte chemoattractant protein production by rat mesangial cells. J Lab Clin Med 124:112-117, 1994
29. 29. YOSHIMURA T, YUHKI N, MOORE SK, APPELLA E, LERMAN MI, LEONARD EJ: Human monocyte chemoattractant protein-1 (MCP-1): Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 244:487-493, 1989
30. 30. YOSHIMURA T, TAKEYA M, TAKAHASHI K: Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines. Biochem Biophys Res Commun 174:504-509, 1991
31. 31. SUSING SD, FOGELMANC AM: Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein. Arterioscler Thromb 12:78-82, 1992
32. 32. POON M, HSU WC, BOGDANOV VY, TAUBMAN MB: Secretion of monocyte chemotactic activity by cultured rat aortic smooth muscle cells in response to PDGF is due predominantly to the induction of JE/MCP-1. Am J Pathol 149:307-317, 1996
33. 33. WENZEL U, SCHNEIDER A, VALENTE AJ, ABBOUD HE, THAISS F, HELMCHEN UM, STAHL RAK: Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 51:770-776, 1997
34. 34. WANG GP, DENG ZD, NI J, QU ZL: Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages. Atherosclerosis 133:31-36, 1997
35. 35. CUSHING SD, BERLINER JA, VALENTE AJ, TERRITO MC, NAVAB M, PARHAMI F, GERRITY R, SCHWARTZ CJ, FOGELMAN AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87:5134-5138, 1990
36. 36. IHM CG, PARK JK, HONG SP, LEE TW, CHO BS, KIM MJ, CHA DR, HA H: A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 79:33-37, 1988
37. 37. SEKIGUCHI M. NATORI Y, IYONAGA K, TAKEYA M, NATORI Y: Expression of monocyte chemoattractant protein-1 in experimental crescentic glomerulonephritis in rats. J Lab Clin Med 129:239-244, 1997
38. 38. TANG WW, QI M, WARREN JS, VAN GY: Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 159:870-876, 1997
39. 39. ROVIN BH, DOE N, TAN LC: Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 27:640-646, 1996
40. 40. CHANA RS, WHEELER DC: Fibronectin augments monocyte adhesion to low-density lipoprotein-stimulated mesangial cells. Kidney Int 55:179-188, 1999
41. 41. ALLEN S, KHAN S, AL-MOHANNA F, BAITEN P, YACOUB M: Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 101:1064-1075, 1998
42. 42. LYNN EG, CHOY PC, MAGIL A, O K: Uptake and metabolism of lipoprotein-X in mesangial cells. Mol Cell Biochem 175:187-194, 1997
43. 43. O K, FROHLICH J: Role of lecithin:cholesterol acyltransferase and apolipoprotein A-1 in cholesterol esterification in lipoprotein-X in vitro. J Lipid Res 36:2344-2354, 1995
44. 44. BATZRI S, KORN ED: Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 298:1015-1019, 1973
45. 45. JOHNSON JE, EDWARDS AS, NEWTON AC: A putative phosphatidyl-serine binding motif is not involved in the lipid regulation of protein kinase C. J Biol Chem 272:30787-30792, 1997
46. 46. EDWARDS AS, NEWTON AC: Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C. J Biol Chem 272:18382-18390, 1997
47. 125I-labeled lipoproteins by skin fibroblasts, smooth muscle cells, and peritoneal macrophages in culture. Am J Pathol 121:200-211, 1985
48. 48. STEPHAN ZF, YURACHEK EC: Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J Lipid Res 34:325-330, 1993
49. 49. VERHOEYE FR, DESCAMPS O, HUSSON B, HONDEKIJN JC, RONVEAUX-DUPAL MF, LONTIE JF, HELLER FR: An improved method for detection of low density lipoprotein receptor defects in human T lymphocytes. J Lipid Res 37:1377-1384, 1996
50. 50. LYNN EG, O K: Role of lipoprotein-X in foam cell formation and rat mesangial cell proliferation. Clin Exp Pharmacol Physiol 24:973-975, 1997
51. 51. OKADA M, MATSUMORI A, ONO K, FURUKAWA Y, SHIOI T, IWASAKI A, MATSUSHIMA K, SASAYAMA S: Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 18:894-901, 1998
52. 52. KATZUNG GC, CHATTERJEE K: Vasodilators and the Treatment of Angina Pectoris, in Basic and Clinical Pharmacology (6th ed), edited by KATZUNG BG, Connecticut, Appleton and Lange, 1995, pp 171-187
53. 53. AL-SHEBEB T, FROHLICH J, MAGIL AB: Glomerular disease in hypercholesterolemic guinea pigs: A pathogenetic study. Kidney Int 33:498-507, 1988
54. 54. GRONE H-J, WALLI A, GRONE E, NIEDMANN P, THIERY J, SEIDEL D, HELMCHEN U: Induction of glomerulosclerosis by dietary lipids: A functional and morphologic study in rat. Lab Invest 60:433-446, 1989
55. 55. KASISKE BL, O'DONNELL MP, SCHMITZ PG, KIM Y, KEANE WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37:880-891, 1990
56. 56. ATTMAN P-O, ALAUPOVIC P: Lipid abnormalities in chronic renal insufficiency. Kidney Int 39(Suppl 31):S16-S23, 1991
57. 57. KEANE WF, MULCAHY WS, KASISKE BL, KIM Y, O'DONNELL MP: Hyperlipidemia and progressive renal disease. Kidney Int 36(Suppl 31):S41-S48, 1991
58. 58. CORITSIDIS G, RIFICI V, GUPTA S, RIE J, SHAN ZH, NEUGARTEN J, SCHLONDORFF D: Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 39:858-866, 1991
59. 59. GREENSPAN P, YU H, MAO F, GUTMAN RL: Cholesterol deposition in macrophages: Foam cell formation mediated by cholesterol-enriched oxidized low density lipoprotein. J Lipid Res 38:101-109, 1997
60. 60. SCHONHOLZER KW, WALDRON M, MAGIL AB: Intraglomerular foam cells and human focal glomerulosclerosis. Nephron 62:130-136, 1992
61. 61. YLA-HERTTUALA S, LIPTON BA, ROSENFELD ME, SARKIOJA T, YOSHIMURA T, LEONALD EJ, WITZTUM JL: Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256, 1991
62. 62. NELKEN NA, COUGHLLIN SR, GORDON D, WILCOX JN: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121-1127, 1991
63. 63. TAKEYA M, YOSHIMURA T, LEONARD EJ, TAKAHASHI K: Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemattractant protein-1 monoclonal antibody. Hum Pathol 24:534-539, 1993
64. 64. DUQUE N, GOMEZ-GUERRERO C, EGIDO J: Interaction of IgA with Fcα receptors of human mesangial cells activates transcription factor nuclear factor-κB and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein-10. J Immunol 159:3474-3482, 1997
65. 65. SAITO T, ATKINS RC: Contribution of mononuclear leukocytes to the progression of experimental focal glomerular sclerosis. Kidney Int 37:1076-1083, 1990
66. 66. STEINBERG D, PARTHASARATHY S, CAREW TE, KHOO JC, WITZUM JL: Modifications of low-density lipoprotein that increase its atherogenecity. N Engl J Med 320:915-924, 1989
67. 67. TAKAHASHI S, KAWARABAYASHI Y, NAKAI T, SAKAI J, YAMAMOTO T: Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89:9252-9256, 1992
68. 68. TAKEMURA T, YOSHIOKA K, AYA N, MURAKAMI K, MATSUMOTO A, ITAKURA H, KODAMA T, SUZUKI H: Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43:918-927, 1993
69. 69. HENRY PD, BENTLEY KI: Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest 68:1366-1369, 1981
70. 70. SCHAEFER HI, HOLD KM, EGAS-KENNIPHAAS JM, VAN DER LAARSE A: Intracellular calcium signaling after binding of low-density lipoprotein to confluent and non-confluent cultures of an endothelial cell line, EA.hy926. Cell Calcium 14:507-516, 1993
71. 71. STRICKBERGER SA, RUSSED LN, PHAIR RD: Evidence for increased aortic plasma membrane calcium transport caused by experimental atherosclerosis in rabbit. Circ Res 62:75-80, 1988
72. 72. UEDA A, OKUDA K, OHNO S, SHIRAI A, IGARASHI T, MATSUNAGA K, FUKUSHIMA J, KAWAMOTO S, ISHIGATSUBO Y, OKUBO T: NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 153:2052-2063, 1994
73. 73. ROVIN BH, DICKERSON JA, TAN LC, HEBERT CA: Activation of nuclear factor-κB correlates with MCP-1 expression by human mesangial cells. Kidney Int 48:1263-1271, 1995
74. 74. SUGIYAMA S, KUGIYAMA K, OGATA N, DOI H, OTA Y, OHGUSHI M, MATSUMURA T, OKA H, YASUE H: Biphasic regulation of transcription factor nuclear factor-κB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol 18:568-576, 1998